Expression changes and clinical significance of serum neuron-specific enolase and squamous cell carcinoma antigen in lung cancer patients after radiotherapy
Authors:
Open Access
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Early serum tumor marker dynamics predict progression-free and overall survival in single PD-1/PD-L1 inhibitor treated advanced NSCLC—A retrospective cohort studyLung Cancer, 2019
- Biomarkers in Lung Cancer Screening: Achievements, Promises, and ChallengesJournal of Thoracic Oncology, 2019
- Identifying the Best Marker Combination in CEA, CA125, CY211, NSE, and SCC for Lung Cancer Screening by Combining ROC Curve and Logistic Regression Analyses: Is It Feasible?Disease Markers, 2018
- Combined detection of estrogen and tumor markers is an important reference factor in the diagnosis and prognosis of lung cancerJournal of Cellular Biochemistry, 2018
- Progress and prospects of early detection in lung cancerOpen Biology, 2017
- Neuron-specific enolase, histopathological types, and age as risk factors for bone metastases in lung cancerTumor Biology, 2017
- Prognostic impact of cytological fluid tumor markers in non-small cell lung cancerTumor Biology, 2015
- A systemic inflammation-based prognostic scores (mGPS) predicts overall survival of patients with small-cell lung cancerTumor Biology, 2014
- Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stages IIIa and IIIb nonsmall cell lung cancer. A meta-analysisCancer, 1995
- Quantitative analysis of carcinoembryonic antigen, squamous cell carcinoma antigen, CA 125, and CA 50 cytosolic content in non-small cell lung cancerCancer, 1994